Fisher Asset Management’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-55,432	Closed	-$101K	–	1049
2024 Q4	$101K	Buy	55,432 +550	+1%	+$1.07K	﹤0.01%	961
2024 Q3	$93.3K	Sell	54,882 -1,190	-2%	-$1.96K	﹤0.01%	912
2024 Q2	$76.8K	Buy	56,072 +1,090	+2%	+$2.2K	﹤0.01%	967
2024 Q1	$206K	Buy	54,982 +28	+0.1%	+$164	﹤0.01%	937
2023 Q4	$539K	Buy	54,954 +72	+0.1%	+$589	﹤0.01%	766
2023 Q3	$458K	Hold	54,882	–	–	﹤0.01%	858
2023 Q2	$730K	Hold	54,882	–	–	﹤0.01%	827
2023 Q1	$636K	Hold	54,882	–	–	﹤0.01%	824
2022 Q4	$449K	Hold	54,882	–	–	﹤0.01%	849
2022 Q3	$319K	Hold	54,882	–	–	﹤0.01%	816
2022 Q2	$243K	Hold	54,882	–	–	﹤0.01%	840
2022 Q1	$499K	Sell	54,882 -10	-0%	-$115	﹤0.01%	730
2021 Q4	$1.12M	Buy	54,892 +6,043	+12%	+$146K	﹤0.01%	623
2021 Q3	$1.25M	Buy	48,849 +13,437	+38%	+$398K	﹤0.01%	582
2021 Q2	$1.24M	Sell	35,412 -23,244	-40%	-$676K	﹤0.01%	584
2021 Q1	$1.95M	Buy	58,656 +1,282	+2%	+$44.9K	﹤0.01%	540
2020 Q4	$1.49M	Sell	57,374 -21,177	-27%	-$360K	﹤0.01%	551
2020 Q3	$775K	Buy	+78,551	New	+$452K	﹤0.01%	594